To better understand and address the impacts of long COVID, the U.S. Food and Drug Administration (FDA) is hosting a public meeting on April 25, 2023 to hear directly from patients and patient representatives.
Summary: Mark Thrun, MD, an infectious disease specialist and lead investigator of several remdesivir studies, believes that remdesivir can remain effective against new and emerging variants of the virus. Many Americans are acting as if the COVID-19 pandemic is over, despite it still being a public health emergency. The US FDA has authorized the first at-home test that can detect COVID-19.
Summary: One study examines the effects of SARS-CoV-2 infection and COVID-19 vaccination on Guillain-Barre Syndrome (GBS). Vaccines have allowed for the mitigation of protective measures against the SARS CoV-2 pandemic, but new variants have been found to have higher transmissibility and reduced vaccine efficacy.
Pandemic Patients is a 501(c)(3) non-profit organization that works to relieve the harm caused by COVID-19 and Post-COVID Conditions.
Prior to using this website, please review our Terms of Use and Privacy Policy.